Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.
about
Efficient non-viral reprogramming of myoblasts to stemness with a single small molecule to generate cardiac progenitor cellsAngiomyogenesis for myocardial repair.Ex vivo delivered stromal cell-derived factor-1alpha promotes stem cell homing and induces angiomyogenesis in the infarcted myocardium.Laser microdissection and capture of pure cardiomyocytes and fibroblasts from infarcted heart regions: perceived hyperoxia induces p21 in peri-infarct myocytes.Role of the renin angiotensin system on bone marrow-derived stem cell function and its impact on skeletal muscle angiogenesisCombining neuropeptide Y and mesenchymal stem cells reverses remodeling after myocardial infarction.Toll-like receptor 2 mediates mesenchymal stem cell-associated myocardial recovery and VEGF production following acute ischemia-reperfusion injuryProinflammatory stem cell signaling in cardiac ischemiaPostinfarct intramyocardial injection of mesenchymal stem cells pretreated with TGF-alpha improves acute myocardial function.Are neonatal stem cells as effective as adult stem cells in providing ischemic protection?Signal transducer and activator of transcription 3-stimulated hypoxia inducible factor-1alpha mediates estrogen receptor-alpha-induced mesenchymal stem cell vascular endothelial growth factor productionSca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusionDe novo myocardial regeneration: advances and pitfalls.TNF receptor 2, not TNF receptor 1, enhances mesenchymal stem cell-mediated cardiac protection following acute ischemia.Reversal of ischemic cardiomyopathy with Sca-1+ stem cells modified with multiple growth factorsGender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1).Local renin-angiotensin system regulates hypoxia-induced vascular endothelial growth factor synthesis in mesenchymal stem cellsMyocardial restoration: is it the cell or the architecture or both?Mesenchymal stem cells overexpressing CXCR4 attenuate remodeling of postmyocardial infarction by releasing matrix metalloproteinase-9.In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function.STAT3 mediates bone marrow mesenchymal stem cell VEGF production.The bone marrow--cardiac axis of myocardial regenerationEnhancing apoptotic cell clearance mitigates bacterial translocation and promotes tissue repair after gut ischemia-reperfusion injury.Myocardial therapeutic angiogenesis: a review of the state of development and future obstaclesBone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study.TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathwaysTGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK- and PI3-K- but not JNK- or ERK-dependent mechanismsStem cells as a potential future treatment of pediatric intestinal disorders.Systems approaches to preventing transplanted cell death in cardiac repair.Nonviral vector gene modification of stem cells for myocardial repair.Genetic modification of stem cells for transplantation.Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function.Reiterated Targeting Peptides on the Nanoparticle Surface Significantly Promote Targeted Vascular Endothelial Growth Factor Gene Delivery to Stem Cells.Stem cell homing and angiomyogenesis in transplanted hearts are enhanced by combined intramyocardial SDF-1alpha delivery and endogenous cytokine signaling.Mobilized bone marrow progenitor cells serve as donors of cytoprotective genes for cardiac repairIL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction.Lin-c-kit(+) BM-derived stem cells repair Infarcted Heart.Optimizing stem cell function for the treatment of ischemic heart diseaseParacrine effects of transplanted myoblasts and relaxin on post-infarction heart remodelling.
P2860
Q27323702-8D7D5A66-11BA-43B1-B8B0-46B415266AA0Q30480151-6E2A41C7-5D82-42AA-B462-96C5FDDC6745Q30486444-5AEED933-D32E-471C-B815-176DB87AB136Q33266095-0DE8A7C0-51B2-4FF3-85FD-328313612BCEQ33587136-4D21B51E-182E-4075-A17A-3666A60C3FBBQ33589174-9EAF79E9-E87B-4DEA-9F3F-EC3A0A2D7F9FQ33840741-CDF26B61-2012-4AAD-99CF-A25210092B82Q33858319-CAEA5C4F-24B8-42C5-8523-7F5669BE0191Q33994997-57C3D3F1-7BD2-42BF-90F7-5E8079717CD2Q34089605-1157C4C4-1068-4D80-BC13-ED52AE57C10AQ34089612-FA7D40CA-4DEA-44E8-A500-075368D24FD6Q34110874-135842F9-4764-40C0-972A-7A7ED6F0DFA0Q34271595-38EA0D4A-9741-4C8A-8DF3-F8EE519D72CAQ34789088-F8BE821C-9C29-4890-922B-C4424B0DDC5EQ35140094-66276C32-62BC-4885-B9A6-0CBA5FC53366Q35606632-AFD1FE1D-7A12-4431-A99B-AAAEC307F4E8Q35632070-F296F7FA-8998-4134-A77F-ADF8989B76FDQ35778889-BFC85841-D6B7-406A-9E30-D41107480E6AQ35809394-F2BCFAA9-7593-43FF-BF39-50BF8C6F0F89Q35855818-78A007A0-A195-4044-AB51-F8C498C23224Q36012519-93A15030-6742-4C00-AFBA-77E53700C1E1Q36174197-B6B31EF1-2C49-4C39-92A8-74AAEF8BFED6Q36613667-ECE0F4AF-095B-4AA9-8F12-C2628F82C31EQ36820684-E66F8AB7-F8FF-4B46-90B8-14ACC5DB77B5Q36844563-5C87CB4C-4376-4B97-A3E0-DE534B8C4060Q36956560-D7BA9AD6-1685-4DA2-A1CD-045F15C68DA9Q36956611-300741EF-5D34-45FB-AEA0-ED730A3CFFEEQ36976592-8E52B132-7589-4592-91E8-5D63C4E1FAB9Q36984663-0F049BB3-1452-448C-98B2-2A18B89E958FQ36994178-8D480A5F-16D8-4690-A0E9-C0E4F93C2CF4Q37010620-EF154E2F-90E8-43DF-9DF7-EDF0E62D4FF8Q37012575-464E904A-0DD1-46D4-8AE7-A0C86BD4BB3DQ37038759-5E00B3E2-41A5-45A1-8EF3-023DCE4EFB8FQ37041753-5E0F21C3-EB50-4C1E-BE3D-19821A1C501EQ37162562-0095B138-1F35-42F7-888D-751F48D853A9Q37199481-CD80A99E-D3C7-41C6-8B9E-6A7CC98337DCQ37363758-2F72117D-4EDD-4F4B-8FFB-708B6640466EQ37536141-F8D76E5D-5E5E-479E-B8C7-9E1400820340Q37786701-47128C9A-1540-4AD0-B3D9-73018A07BA3DQ39740814-AE56B55B-11E6-470A-B0EC-0AD4DF83AAA7
P2860
Combining pharmacological mobilization with intramyocardial delivery of bone marrow cells over-expressing VEGF is more effective for cardiac repair.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Combining pharmacological mobi ...... effective for cardiac repair.
@ast
Combining pharmacological mobi ...... effective for cardiac repair.
@en
type
label
Combining pharmacological mobi ...... effective for cardiac repair.
@ast
Combining pharmacological mobi ...... effective for cardiac repair.
@en
prefLabel
Combining pharmacological mobi ...... effective for cardiac repair.
@ast
Combining pharmacological mobi ...... effective for cardiac repair.
@en
P2093
P1476
Combining pharmacological mobi ...... effective for cardiac repair.
@en
P2093
Husnain K Haider
Meifeng Xu
Muhammad Ashraf
Nauman Ahmad
Yigang Wang
P304
P356
10.1016/J.YJMCC.2006.02.004
P50
P577
2006-05-01T00:00:00Z